APP insider sale notice: 30,000 RSUs via Morgan Stanley on 08/22/2025
Rhea-AI Filing Summary
Applovin Corporation (APP) Form 144 states that 30,000 shares of common stock, issued as Restricted Stock Units on 05/29/2024, are proposed for sale through Morgan Stanley Smith Barney LLC with an approximate sale date of 08/22/2025. The filing reports an aggregate market value of $12,562,800 versus 307,636,373 shares outstanding. The RSUs were acquired from the issuer and payment was recorded on 05/29/2024. The notice also discloses multiple recent 10b5-1 sales on 05/23/2025 totaling 82,500 shares with stated gross proceeds for each transaction. The filer certifies no undisclosed material adverse information and provides broker and trust addresses for the transactions.
Positive
- Full disclosure of planned sale: filing specifies shares (30,000), acquisition date (05/29/2024), broker (Morgan Stanley Smith Barney LLC) and planned sale date (08/22/2025).
- Transparency on prior 10b5-1 sales: lists recent 05/23/2025 sales totaling 82,500 shares with gross proceeds disclosed for each transaction.
Negative
- None.
Insights
TL;DR: Routine insider sale notice; transparent disclosure of planned RSU sale and recent 10b5-1 activity.
The Form 144 is a standard compliance filing showing the planned sale of 30,000 RSUs granted on 05/29/2024, to be executed through Morgan Stanley on or about 08/22/2025. The filing provides positions, acquisition dates, and aggregate market value, and lists prior 10b5-1 sales on 05/23/2025 totaling 82,500 shares. From an investor-monitoring perspective, this is orderly disclosure of insider liquidity rather than an operational development; it offers clarity on share movement but no new financial performance information.
TL;DR: Compliance-focused filing; affirms use of trading plans and attestation to lack of undisclosed material information.
The document confirms the filer relied on issuer-granted Restricted Stock Units and discloses reliance on 10b5-1 plans for recent sales, indicating governance processes for insider trading. The signature attestation required by the form is present. This filing addresses disclosure and procedural compliance and does not signal corporate governance changes or material events affecting the company’s operations.